C12N 2750/14034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2750/14034 (Use of virus or viral component as vaccine) appears on 30 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 30
- Published applications
- 42
- Assignees
- 29
- Inventors
- 84
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 1 | 2 |
| 2009 | 0 | 3 |
| 2010 | 1 | 2 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 4 |
| 2016 | 3 | 2 |
| 2017 | 2 | 1 |
| 2018 | 2 | 1 |
| 2019 | 2 | 0 |
| 2020 | 0 | 4 |
| 2021 | 1 | 3 |
| 2022 | 4 | 4 |
| 2023 | 4 | 3 |
| 2024 | 2 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Methods of vaccine administration6 May 2025US 12,290,559 B2Zoetis Services LLC
- Recombinant porcine parvovirus antigenic protein and use thereof24 Sep 2024US 12,097,255 B2Bioapplications Inc.
- Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof13 Feb 2024US 11,896,659 B2
- Paramyxoviridae expression system22 Aug 2023US 11,730,805 B2Boehringer Ingelheim Vetmedica GmbH
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof12 Mar 2026US 2026/0069672 A1Boehringer Ingelheim Vetmedica GmbH
- Method for inhibiting zophobas morio black wasting disease24 Apr 2025US 2025/0127883 A1Rutgers, The State University of New Jersey
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof11 Jul 2024US 2024/0226264 A1Boehringer Ingelheim Vetmedica GmbH
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof28 Sep 2023US 2023/0302113 A1Boehringer Ingelheim Animal Health USA Inc.
- Methods Of Vaccine Administration16 Mar 2023US 2023/0078668 A1Zoetis Services LLC
Most cited
By later US patents
- Method for treating viral diseases with attenuated virus13US 5,124,148 AUnited Cancer Research Institute · 1992
- Canine combination vaccines6US 7,736,658 B2Pfizer Inc. · 2010
- Liquid stable virus vaccines5US 9,314,519 B2Intervet Inc. · 2016
- Dry formulations of vaccines that are room temperature stable5US 9,839,613 B2Intervet Inc. · 2017
- Cell cultures4US 4,021,302 ABurroughs Wellcome Co. · 1977